Connecting the community: Social media used for panel discussion

Article

A Corporate Social Responsibility (CSR) panel discussion will be held by the International Agency for the prevention of Blindness (IAPB) solely via social networking.

A Corporate Social Responsibility (CSR) panel discussion will be held by the International Agency for the prevention of Blindness (IAPB) solely via social networking.

Everyone in the ophthalmic community is encouraged to submit questions via Facebook, Twitter and email. International industry leaders will then answer the questions and offer suitable advice.

The CSR panellists include Caroline Roan, president of the Pfizer foundation, Alcon’s Strategic Markets Medical Director in Asia, Dr Hunter Cherwek and Claude Darnault, Chief Sustainability Officer at Essilor in France.

Phillip Albano, Coordinator of the CSR panel stated, "Whether it’s providing financial or in-kind support, CSR plays a critical role in national eye care systems. Less understood though is the considerations businesses take into account before entering into private/public partnerships. During the symposium, leaders in the field will explore the theory and practice of CSR, highlight key public/private partnerships and discuss ways in which the private sector, governments, NGOs and others might partner more effectively in the future."

To register or found out more information on the IAPB please visit www.9ga.iapb.org

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
© 2025 MJH Life Sciences

All rights reserved.